Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Sarcoma

Silvia Stacchiotti

西尔维娅·斯塔基奥蒂

MD

🏢Fondazione IRCCS Istituto Nazionale Tumori(国家肿瘤研究所基金会IRCCS)🌐Italy

Medical Oncologist, Sarcoma Service肉瘤科肿瘤内科医生

48
h-index
1
Key Papers
2
Awards
1
Key Contributions

👥Biography 个人简介

World expert in chordoma and PEComa, two rare and therapeutically challenging tumor types. Has led international consensus meetings and prospective trials defining treatment standards for these rare sarcoma entities, establishing imatinib in solitary fibrous tumor and mTOR inhibitors in PEComa.

Share:

🧪Research Fields 研究领域

Sarcoma肉瘤
Soft Tissue Sarcoma软组织肉瘤
GIST胃肠间质瘤

🎓Key Contributions 主要贡献

Chordoma and PEComa Treatment

Authored international consensus guidelines for chordoma management and led clinical studies demonstrating activity of imatinib in solitary fibrous tumor and mTOR inhibitors in PEComa, establishing evidence-based treatment algorithms for rare STS.

Representative Works 代表性著作

[1]

Chordoma: malignant when resected late, metastatic, locally relapsed, or unresectable: a systematic review

The Lancet Oncology (2015)

Comprehensive systematic review defining the natural history and treatment outcomes of chordoma, guiding multidisciplinary management.

🏆Awards & Recognition 奖项与荣誉

🏆Connective Tissue Oncology Society Award for Rare Sarcoma Research
🏆Italian Cancer Society Young Investigator Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 西尔维娅·斯塔基奥蒂 的研究动态

Follow Silvia Stacchiotti's research updates

留下邮箱,当我们发布与 Silvia Stacchiotti(Fondazione IRCCS Istituto Nazionale Tumori)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment